Anti-dual integrin antibodies, compositions, methods and uses

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 37/00 (2006.01) C07K 16/28 (2006.01) C07K 16/42 (2006.01) C12N 5/10 (2006.01) C12N 15/79 (2006.01) G01N 33/50 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2418962

The present invention relates to at least one novel anti-dual integrin antibodies, including isolated nucleic acids that encode at least one anti- dual integrin antibody, dual integrin, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

L'invention concerne au moins un nouvel anticorps anti-intégrine double, notamment des acides nucléiques isolés codant au moins pour un anticorps dirigé contre une intégrine double; elle concerne également une intégrine double, des vecteurs, cellules hôtes, animaux ou plantes transgéniques, ainsi que des procédés de préparation et d'utilisation de ces anticorps, notamment des compositions thérapeutiques; elle concerne encore des procédés et dispositifs associés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-dual integrin antibodies, compositions, methods and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-dual integrin antibodies, compositions, methods and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-dual integrin antibodies, compositions, methods and uses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1861896

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.